Venture pitch
2025InfectiPatch
An investor-style venture pitch for a microneedle biosensor patch monitoring post-surgical infection through interstitial-fluid biomarkers.
The concept
InfectiPatch is a microneedle biosensor patch for post-surgical infection monitoring: it reads inflammatory and metabolic biomarkers (IL-6, CRP, procalcitonin and lactate) from interstitial fluid, flagging infection hours before clinical signs appear.
The pitch
The work was the full investor framing: the clinical need and cost of surgical site infection, the sensing approach and its evidence base, competitive landscape, development and regulatory pathway, and the commercial case, built to investor standard and delivered as a pitch.
Next step
Get in touch.
A thirty-minute call is enough to tell whether I can help. If I can, you'll get a scoped proposal: defined deliverables, a fixed fee or day rate, and a start date. If I can't, I'll say so on the call.
Open to short-term contracts, fixed-scope projects and part-time roles.